Safety of non-steroidal anti-inflammatory drugs during pregnancy and lactation
暂无分享,去创建一个
[1] U. Simeoni,et al. Neonatal renal dysfunction and intrauterine exposure to prostaglandin synthesis inhibitors , 2004, European Journal of Pediatrics.
[2] I. Matheson,et al. Piroxicam in breast milk after long-term treatment , 2004, European Journal of Clinical Pharmacology.
[3] M. Østensen. Piroxicam in human breast milk , 2004, European Journal of Clinical Pharmacology.
[4] S. Carlan,et al. Outpatient Oral Sulindac to Prevent Recurrence of Preterm Labor , 1995, Obstetrics and gynecology.
[5] M. Østensen. Optimisation of Antirheumatic Drug Treatment in Pregnancy , 1994 .
[6] B. Sibai,et al. Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy. , 1994, American journal of obstetrics and gynecology.
[7] Jeffrey R. Wilson,et al. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women , 1994, The Lancet.
[8] D. Lewis,et al. Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate , 1994 .
[9] F. Witter. Clinical Pharmacokinetics in the Treatment of Rheumatoid Arthritis in Pregnancy , 1993, Clinical Pharmacokinetics.
[10] K. Moise,et al. The Effect of Gestational Age and Fetal Indomethacin Levels on the Incidence of Constriction of the Fetal Ductus Arteriosus , 1993, Obstetrics and gynecology.
[11] H. Madhav,et al. Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: a randomized study. , 1993, American journal of obstetrics and gynecology.
[12] Italianstudyofaspirininpregna. Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension , 1993 .
[13] P. Merlob,et al. NSAIDs: Maternal and Fetal Considerations , 1992, American journal of reproductive immunology.
[14] D. Mastrogiannis,et al. Randomized Comparative Trial of Indomethacin and Sulindac for the Treatment of Refractory Preterm Labor , 1992, Obstetrics and gynecology.
[15] B. Luke,et al. The Association Between Maternal Weight Gain and the Birthweight of Twins , 1992 .
[16] K. Ilett,et al. Excretion of indomethacin in breast milk. , 1991, British journal of clinical pharmacology.
[17] J. Gouyon,et al. [Neonatal kidney insufficiency and intrauterine exposure to ketoprofen]. , 1991, Archives francaises de pediatrie.
[18] D. Wurtzel. Prenatal Administration of Indomethacin as a Tocolytic Agent: Effect on Neonatal Renal Function , 1990, Obstetrics and gynecology.
[19] J. Elliott,et al. Oligohydramnios in each sac of a triplet gestation caused by Motrin--fulfilling Kock's postulates. , 1990, American journal of obstetrics and gynecology.
[20] G. Greenberg,et al. Drugs in Pregnancy and Lactation , 1990 .
[21] S. Shapiro,et al. The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects , 1989, The New England journal of medicine.
[22] D. Nyberg,et al. The association between decreased amniotic fluid volume and treatment with nonsteroidal anti-inflammatory agents for preterm labor , 1989 .
[23] J. G. Carrasco,et al. Anemia aguda, rectorragia y hematuria asociadas a la ingestión de naproxén , 1989 .
[24] D S Sharif,et al. Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. , 1988, The New England journal of medicine.
[25] K. Rothman,et al. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. , 1985, The New England journal of medicine.
[26] D. Dudley,et al. Fetal and neonatal effects of indomethacin used as a tocolytic agent. , 1985, American journal of obstetrics and gynecology.
[27] K. Woods. MEDICARE: A NEW HEALTH INSURANCE PROGRAMME FOR AUSTRALIA , 1984, The Lancet.
[28] F. Jamali,et al. Naproxen excretion in milk and its uptake by the infant. , 1983, Drug intelligence & clinical pharmacy.
[29] K. Momma,et al. Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs. , 1983, Prostaglandins.
[30] M. Stuart,et al. Effects of Acetylsalicylic Acid Ingestion on Maternal and Neonatal Hemostasis , 1982 .
[31] B. Rumack,et al. Neonatal Intracranial Hemorrhage and Maternal Use of Aspirin , 1981, Obstetrics and gynecology.
[32] W. Wilson,et al. A 16-Day-Old Breast-fed Infant with Metabolic Acidosis Caused by Salicylate , 1981 .
[33] A. Wilkinson. NAPROXEN LEVELS IN PRETERM INFANTS AFTER MATERNAL TREATMENT , 1980, The Lancet.
[34] R. White,et al. The inhibition of premature labor with indomethacin. , 1980, American journal of obstetrics and gynecology.
[35] M. Mitchell,et al. Persistent pulmonary hypertension and abnormal prostaglandin E levels in preterm infants after maternal treatment with naproxen. , 1979, Archives of disease in childhood.
[36] F. Raucci,et al. [Use of ketoprofen in threatened preterm labor]. , 1979, Minerva ginecologica.
[37] O. Eeg‐Olofsson,et al. CONVULSIONS IN A BREAST-FED INFANT AFTER MATERNAL INDOMETHACIN , 1978, The Lancet.
[38] R. L. Jordan,et al. Indomethacin: studies of absorption and placental transfer. , 1977, American journal of obstetrics and gynecology.
[39] J. Tourville. Birth Defects and Drugs in Pregnancy , 1977 .
[40] S. Shapiro,et al. ASPIRIN AND CONGENITAL MALFORMATIONS , 1976, The Lancet.
[41] G. Turner,et al. MATERNAL EFFECTS OF REGULAR SALICYLATE INGESTION IN PREGNANCY , 1975, The Lancet.
[42] G. Turner,et al. FETAL EFFECTS OF REGULAR SALICYLATE INGESTION IN PREGNANCY , 1975, The Lancet.
[43] G. Levy,et al. Distribution of salicylate between neonatal and maternal serum at diffusion equilibrium , 1975, Clinical pharmacology and therapeutics.
[44] H. Zuckerman,et al. Inhibition of Human Premature Labor by Indomethacin , 1974, Obstetrics and gynecology.
[45] J. Schulman,et al. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. , 1973, Lancet.
[46] I. Pless,et al. West Indian one-year-olds. A comparative analysis of health and service utilisation. , 1967, Lancet.